MetLife/$MET
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About MetLife
MetLife is one of the largest life insurers in the US by assets and provides a variety of life insurance and annuity products. It is organized into six segments: Group Benefits, Retirement and Income Solutions, Asia, Latin America, Europe/Middle East/Africa (EMEA), and MetLife Holdings (products in run-off). Group Benefits and RIS are US-based, contributing to around 48% of the firm's 2024 adjusted earnings. The Asia segment contributes around 25% of earnings, mainly tied to Japan. The company also holds leading market positions in Mexico and Chile, with the Latin America segment contributing around 13% of 2024 earnings. The EMEA and MetLife Holdings segments contributed around 4% and 10% of 2024 earnings, respectively.
Ticker
$MET
Sector
Primary listing
NYSE
Employees
45,000
Headquarters
Website
MetLife Metrics
BasicAdvanced
$52B
13.24
$5.93
0.85
$2.23
2.89%
Price and volume
Market cap
$52B
Beta
0.85
52-week high
$88.09
52-week low
$65.21
Average daily volume
3.4M
Dividend rate
$2.23
Financial strength
Current ratio
1.608
Quick ratio
1.364
Long term debt to equity
96.555
Total debt to equity
172.245
Dividend payout ratio (TTM)
39.96%
Interest coverage (TTM)
6.27%
Profitability
EBITDA (TTM)
7,248
Gross margin (TTM)
25.66%
Net profit margin (TTM)
5.87%
Operating margin (TTM)
8.95%
Effective tax rate (TTM)
24.66%
Revenue per employee (TTM)
$1,620,000
Management effectiveness
Return on assets (TTM)
0.59%
Return on equity (TTM)
15.51%
Valuation
Price to earnings (TTM)
13.24
Price to revenue (TTM)
0.738
Price to book
1.89
Price to tangible book (TTM)
2.82
Price to free cash flow (TTM)
3.582
Free cash flow yield (TTM)
27.92%
Free cash flow per share (TTM)
21.906
Dividend yield (TTM)
2.84%
Forward dividend yield
2.89%
Growth
Revenue change (TTM)
6.17%
Earnings per share change (TTM)
61.27%
3-year revenue growth (CAGR)
2.46%
10-year revenue growth (CAGR)
0.05%
3-year earnings per share growth (CAGR)
-1.26%
10-year earnings per share growth (CAGR)
0.01%
3-year dividend per share growth (CAGR)
4.32%
10-year dividend per share growth (CAGR)
4.45%
What the Analysts think about MetLife
Analyst ratings (Buy, Hold, Sell) for MetLife stock.
Bulls say / Bears say
MetLife announced a $3 billion share buyback program with its Q1 2025 results, highlighting management’s focus on returning capital to shareholders (Reuters)
MetLife’s adjusted premiums and revenues rose 16.5% year-over-year to $13.61 billion in Q1 2025, showing robust demand across its insurance and annuities business lines (Reuters)
Net investment income increased 9% to $5.7 billion in Q2 2025, driven by higher yields amid rising interest rates and strengthening overall earnings prospects (Reuters)
Second-quarter 2025 adjusted profit dropped 16% from a year earlier to $1.36 billion, reflecting weaker underwriting margins in the life and non-medical health insurance businesses (Reuters)
Premiums, fees, and other revenues decreased 6% in Q2 2025 to $12.72 billion, pointing to weaker sales and the effects of less favorable market conditions on underwriting volume (Reuters)
MetLife shares are down nearly 7% year-to-date in 2025, lagging broader market indices as investors worry about profit volatility (Reuters)
Data summarised monthly by Lightyear AI. Last updated on 2 Oct 2025.
MetLife Financial Performance
Revenues and expenses
MetLife Earnings Performance
Company profitability
MetLife News
AllArticlesVideos
MetLife to Hold Conference Call for Third Quarter 2025 Results
Business Wire1 week ago
MetLife Declares Fourth Quarter 2025 Common Stock Dividend
Business Wire2 weeks ago
MetLife and Global Citizen Announce Major Partnership to Drive Economic Change and Foster Resilient Communities
Business Wire3 weeks ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
FAQs
What’s the current market cap for MetLife stock?
MetLife (MET) has a market cap of $52B as of October 18, 2025.
What is the P/E ratio for MetLife stock?
The price to earnings (P/E) ratio for MetLife (MET) stock is 13.24 as of October 18, 2025.
Does MetLife stock pay dividends?
Yes, the MetLife (MET) stock pays dividends to shareholders. As of October 18, 2025, the dividend rate is $2.225 and the yield is 2.89%. MetLife has a payout ratio of 39.96% on a trailing twelve-month basis.
When is the next MetLife dividend payment date?
The next MetLife (MET) dividend payment is scheduled for December 09, 2025.
What is the beta indicator for MetLife?
MetLife (MET) has a beta rating of 0.85. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.